English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12500/13673 (91%)
造訪人次 : 2587821      線上人數 : 382
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/16407


    題名: Associations between polygenic risk score for schizophrenia and schizotypal traits in the multiplex families of patients with schizophrenia
    作者: Chen, WJ;Jen, YW;Yu, SL;Hsiao, PC;Yu, SC;Liu, CM;Liu, CC;Hwang, TJ;Hsieh, MH;Chien, YL;Lin, YT;Faraone, SV;Tsuang, MT;Hwu, HG
    貢獻者: Center for Neuropsychiatric Research
    摘要: Background: A possible connection between schizotypy and schizophrenia (SZ) might be attributable to their overlapping genetic determinants in terms of the polygenic risk score (PRS). Using multiplex SZ families, this study aims to (1) investigate the relationship of the PRS for SZ (SZ-PRS) and dimensional schizotypal traits, including schizophrenic symptom in the patients with SZ and schizotypy in their unaffected relatives; (2) evaluate the changes of the association patterns of SZ-PRS and dimensional schizotypal traits after combining patients with their unaffected relatives; and (3) examine whether the dimensional schizotypal traits were also associated with PRS for general personality, bipolar disorder (BIP), and major depression disorder (MDD). Methods: Among 557 multiplex families recruited in Taiwan Schizophrenia Linkage Study, 1275 individuals were genotyped using Illumina PsychChip array. A total of 538 patients and their 543 unaffected relatives from 315 families, who had passed the quality control and completed the measurements of schizotypal traits, were included for subsequent analyses. A modified Structured Interview for Schizotypy were used for assessing schizotypy factors among unaffected relatives and the Scales for Positive and Negative Symptoms for assessing schizophrenic symptom factors among patients. A PRS was derived first using the summary statistics of the GWAS from the Psychiatric Genomic Consortium-2 SZ cohort as the discovery dataset, and then a weighted sum of SNPs was calculated using the logarithm of each SNP's odds ratio for the effect allele from the discovery dataset. Results: Among the three groups of participants (538 patients, 53 unaffected siblings, and 490 unaffected parents), both patients and unaffected siblings had similar age and educational levels, whereas parents had lower educational levels compared to their offspring. An alignment approach was used to derive the 2-factor schizotypal trait (i.e., the Aligned Positive Schizophrenic-Schizotypy and the Aligned Negative Schizophrenic-Schizotypy factor). We found that the SZ-PRS was correlated only with Disorganization factor from three Schizophrenic symptom factors in the patients as well as with Social isolation/Introversion factor from four Schizotypy factors in their unaffected relatives. Second, after pooling patients and their unaffected relatives, SZ-PRS explained more variance of Aligned Negative Schizophrenic-Schizotypy factor than that of Aligned Positive Schizophrenic-Schizotypy factor. Also, the association effects were slightly increased in the pooled sample compared to that of analyzing patients and unaffected relatives separately. Finally, Aligned Schizophrenic-Schizotypy factors were only associated with SZ-PRS but not with PRS for BIP, MDD, or general personality traits. Discussion: To our knowledge, this is the first study using multiplex SZ families to exam the association of schizotypal traits (including four Schizotypy factors, three Schizophrenic symptom factors, and two Aligned Schizophrenic-Schizotypy factors) and polygenic risk of SZ. Our findings indicated that SZ-PRS only correlated with specific individual dimension (i.e., Social isolation/Introversion factor) of schizotypy in unaffected relatives of patients with SZ. These results offer support to the hypotheses that the negative dimension of schizotypy reflects more the genetic vulnerability to SZ than the positive dimension of schizotypy.
    日期: 2024-10
    關聯: European Neuropsychopharmacology. 2024 Oct;87(Suppl. 1):194.
    Link to: http://dx.doi.org/10.1016/j.euroneuro.2024.08.385
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:001336799000334
    顯示於類別:[陳為堅] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI001336799000334.pdf61KbAdobe PDF24檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋